Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IAPP | P10997 | 1/20 | 0.56 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | NQO2 | P16083 | 1/20 | 0.50 |
| ▸ | ACP3 | P15309 | 1/20 | 0.49 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30258002 | 1.00 | IAPP (0.56) | IAPPMTNR1ATDP1CDYLALDH1A1 | |
| SCHEMBL6282199 | 0.90 | MTNR1A (0.50) | IAPPMTNR1ATDP1CDYLALDH1A1 | |
| SCHEMBL29137509 | 0.85 | ACP3 (0.52) | MTNR1ATDP1CDYLGPR84KDM4E | |
| SCHEMBL7340131 | 0.85 | TDP1 (0.58) | IAPPMTNR1ATDP1CDYLGPR84 | |
| SCHEMBL31043020 | 0.84 | IAPP (0.51) | IAPPMTNR1AALDH1A1LMNAKDM4E | |
| SCHEMBL30307853 | 0.83 | TDP1 (0.67) | MTNR1ATDP1CDYLGPR84KDM4E | |
| SCHEMBL1566760 | 0.83 | TDP1 (0.56) | MTNR1ATDP1CDYLGPR84KDM4E | |
| SCHEMBL1218835 | 0.83 | TDP1 (0.67) | MTNR1ATDP1CDYLGPR84KDM4E | |
| SCHEMBL8093164 | 0.82 | MTNR1A (0.53) | MTNR1ATDP1CDYLGPR84KDM4E | |
| SCHEMBL8400463 | 0.82 | IAPP (0.58) | IAPPMTNR1ATDP1CDYLGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109922793-A | Poorly water soluble dietary supplements and methods of solubilizing pharmaceutically active agents | 雅典娜股份公司 | 2019-06-21 | — | — | CN | claimed |
| CN-106456637-A | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | 特克尼梅德医疗技术股份公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106413714-A | Pharmaceutical use of (R) -pirlindole and pharmaceutically acceptable salts thereof | 特克尼梅德医疗技术股份公司 | 2017-02-15 | — | — | CN | claimed |
| CN-1388110-A | Preparation of naphthalenebutanone with 4-substituted 2-butanone | HOECHST CELANESE CORP (US) | 2003-01-01 | — | — | CN | claimed |
| CN-1214668-A | Preparation of nabumetone from 4-substituted 2-butanone | HOECHST CELANESE CORP (US) | 1999-04-21 | — | — | CN | claimed |
| CN-1079954-A | The naphthalene butanone of spray chilling and its production method | SMITHKLING BEECHAM PLC (GB) | 1993-12-29 | — | — | CN | claimed |
| US-12521410-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2026-01-13 | — | — | US | disclosed |
| US-20240180945-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2024-06-06 | — | — | US | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| WO-2023072971-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| CN-115836062-A | Compound and medical application thereof | 心悦生医股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-1998050033-A1 | COX-2 SELECTIVE CARPROFEN FOR TREATING PAIN AND INFLAMMATION IN DOGS | PFIZER INC. (US) | 1998-11-12 | — | — | WO | disclosed |
| US-5777170-A | Process for the preparation of a naphthylbutanone | ARCHIMICA SPA (IT) | 1998-07-07 | — | — | US | disclosed |
| EP-0822174-A1 | Process for the preparation of a naphthylbutanone | Archimica S.p.A. (IT) | 1998-02-04 | — | — | EP | disclosed |
| CN-1117484-A | Fatty acid derivatives | SCOTIA HOLDINGS PLC (GB) | 1996-02-28 | — | — | CN | disclosed |
| CN-1079954-A | The naphthalene butanone of spray chilling and its production method | SMITHKLING BEECHAM PLC (GB) | 1993-12-29 | — | — | CN | disclosed |
| CN-1079954-A | The naphthalene butanone of spray chilling and its production method | SMITHKLING BEECHAM PLC (GB) | 1993-12-29 | — | — | CN | disclosed |
| CN-1079954-A | The naphthalene butanone of spray chilling and its production method | SMITHKLING BEECHAM PLC (GB) | 1993-12-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | HRH4, OR10J3, CYP3A5 | IAPP 3212/4885MTNR1A 1717/4885TDP1 4760/4885 |
| US-20240180945-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | HRH4, OR10J3, CYP3A5 | IAPP 3212/4885MTNR1A 1717/4885TDP1 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.